Following the completion of KKR’s acquisition of The Nature's Bounty Co., consumer healthcare veteran Paul Sturman assumed the role of Chief Executive Officer, succeeding Steve Cahillane who stepped down to pursue another opportunity.
“Paul is a very well regarded leader in the consumer healthcare space, having grown and transformed several companies and brands over the years,” said Nate Taylor, Head of Consumer Retail at KKR. “He’s a great fit to lead Nature’s Bounty in its next stage of growth.”
“I am honored to join the team at Nature’s Bounty and to lead this impressive platform,” said Sturman. “There are tremendous opportunities to grow Nature’s Bounty’s footprint in this rapidly expanding global wellness industry, and I look forward to working with the many talented people at Nature’s Bounty to provide the Company’s valued customers with the world’s best health and wellness offerings.”
Sturman has more than 30 years of experience in the consumer healthcare sector with Pfizer, Johnson & Johnson, and Warner-Lambert. Paul spent six years successfully leading Pfizer’s $3+ billion Consumer Healthcare business (formerly Wyeth), which includes major household brands such as Advil, Centrum, Chapstick, Nexium 24Hour, Robitussin, and Emergen-C. he also previously served as Chairman of the Consumer Health Products Association (CHPA).